The Human Pancreatic Islet Transcriptome: Expression of Candidate Genes for Type 1 Diabetes and the Impact of Pro-Inflammatory Cytokines

Type 1 diabetes (T1D) is an autoimmune disease in which pancreatic beta cells are killed by infiltrating immune cells and by cytokines released by these cells. Signaling events occurring in the pancreatic beta cells are decisive for their survival or death in diabetes. We have used RNA sequencing (RNA–seq) to identify transcripts, including splice variants, expressed in human islets of Langerhans under control conditions or following exposure to the pro-inflammatory cytokines interleukin-1β (IL-1β) and interferon-γ (IFN-γ). Based on this unique dataset, we examined whether putative candidate genes for T1D, previously identified by GWAS, are expressed in human islets. A total of 29,776 transcripts were identified as expressed in human islets. Expression of around 20% of these transcripts was modified by pro-inflammatory cytokines, including apoptosis- and inflammation-related genes. Chemokines were among the transcripts most modified by cytokines, a finding confirmed at the protein level by ELISA. Interestingly, 35% of the genes expressed in human islets undergo alternative splicing as annotated in RefSeq, and cytokines caused substantial changes in spliced transcripts. Nova1, previously considered a brain-specific regulator of mRNA splicing, is expressed in islets and its knockdown modified splicing. 25/41 of the candidate genes for T1D are expressed in islets, and cytokines modified expression of several of these transcripts. The present study doubles the number of known genes expressed in human islets and shows that cytokines modify alternative splicing in human islet cells. Importantly, it indicates that more than half of the known T1D candidate genes are expressed in human islets. This, and the production of a large number of chemokines and cytokines by cytokine-exposed islets, reinforces the concept of a dialog between pancreatic islets and the immune system in T1D. This dialog is modulated by candidate genes for the disease at both the immune system and beta cell level.

[1]  C B Wollheim,et al.  Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. , 1992, Endocrinology.

[2]  N. Welsh,et al.  Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Welsh,et al.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. , 1994, The Journal of clinical investigation.

[4]  N. Welsh,et al.  Differences in the Expression of Heat-Shock Proteins and Antioxidant Enzymes between Human and Rodent Pancreatic Islets: Implications for the Pathogenesis of Insulin-Dependent Diabetes Mellitus , 1995, Molecular medicine.

[5]  A. Karsan,et al.  Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1* , 1996, The Journal of Biological Chemistry.

[6]  R. Scharfmann,et al.  Expression of Neuronal Traits in Pancreatic Beta Cells , 1997, The Journal of Biological Chemistry.

[7]  S. Lenzen,et al.  Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells , 1997, Diabetes.

[8]  Robert B Darnell,et al.  Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability , 2000, Neuron.

[9]  T. Mandrup-Poulsen,et al.  A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis , 2001, Diabetologia.

[10]  C. Mathieu,et al.  Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells , 2001, Diabetologia.

[11]  M. Kruhøffer,et al.  Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. , 2001, Diabetes.

[12]  M. Redondo,et al.  Genetics of type 1A diabetes. , 2001, Recent progress in hormone research.

[13]  Dongbo Liu,et al.  Double-Stranded RNA Cooperates with Interferon-γ and IL-1β to Induce Both Chemokine Expression and Nuclear Factor-κB-Dependent Apoptosis in Pancreatic β-Cells: Potential Mechanisms for Viral-Induced Insulitis and β-Cell Death in Type 1 Diabetes Mellitus. , 2002, Endocrinology.

[14]  Christopher J. Lee,et al.  A genomic view of alternative splicing , 2002, Nature Genetics.

[15]  C. Furusawa,et al.  Zipf's law in gene expression. , 2002, Physical review letters.

[16]  Jernej Ule,et al.  CLIP Identifies Nova-Regulated RNA Networks in the Brain , 2003, Science.

[17]  D. Eizirik,et al.  Expression of adiponectin receptors in pancreatic beta cells. , 2003, Biochemical and biophysical research communications.

[18]  Gene microarray study corroborates proteomic findings in rodent islet cells. , 2003, Journal of proteome research.

[19]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[20]  R. Darnell,et al.  Nova Regulates GABAA Receptor γ2 Alternative Splicing via a Distal Downstream UCAU-Rich Intronic Splicing Enhancer , 2003, Molecular and Cellular Biology.

[21]  A. K. Cardozo,et al.  Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic beta-cells. , 2003, Diabetes.

[22]  C. Mathieu,et al.  IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice , 2003, Diabetologia.

[23]  Mogens Kruhøffer,et al.  Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. , 2003, Diabetes.

[24]  U. Boggi,et al.  Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  Christopher J. Lee,et al.  Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data. , 2004, Nucleic acids research.

[26]  F. Ortis,et al.  Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. , 2005, Diabetes.

[27]  S. Akira,et al.  Toll-like Receptor 3 and STAT-1 Contribute to Double-stranded RNA+ Interferon-γ-induced Apoptosis in Primary Pancreatic β-Cells* , 2005, Journal of Biological Chemistry.

[28]  U. Boggi,et al.  Functional and molecular defects of pancreatic islets in human type 2 diabetes. , 2005, Diabetes.

[29]  P. Rorsman,et al.  Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels. , 2005, Genome research.

[30]  R. Lahesmaa,et al.  Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets , 2005, Diabetologia.

[31]  Brian J. Smith,et al.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.

[32]  Alvin C. Powers,et al.  Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[33]  F. Ortis,et al.  Cytokine-induced proapoptotic gene expression in insulin-producing cells is related to rapid, sustained, and nonoscillatory nuclear factor-kappaB activation. , 2006, Molecular endocrinology.

[34]  David Haussler,et al.  Unusual Intron Conservation near Tissue-Regulated Exons Found by Splicing Microarrays , 2005, PLoS Comput. Biol..

[35]  Camillo Ricordi,et al.  The unique cytoarchitecture of human pancreatic islets has implications for islet cell function , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  U. Boggi,et al.  The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients , 2007, Diabetologia.

[37]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[38]  Junying Yuan,et al.  Selective Inhibition of Eukaryotic Translation Initiation Factor 2α Dephosphorylation Potentiates Fatty Acid-induced Endoplasmic Reticulum Stress and Causes Pancreatic β-Cell Dysfunction and Apoptosis* , 2006, Journal of Biological Chemistry.

[39]  Tatiana Tatusova,et al.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..

[40]  J. Ule,et al.  Evolution of Nova-Dependent Splicing Regulation in the Brain , 2007, PLoS genetics.

[41]  P. Taylor,et al.  Expression of neurexin, neuroligin, and their cytoplasmic binding partners in the pancreatic beta-cells and the involvement of neuroligin in insulin secretion. , 2008, Endocrinology.

[42]  Tsonwin Hai,et al.  Initiation and execution of lipotoxic ER stress in pancreatic β-cells , 2008, Journal of Cell Science.

[43]  S. Lira,et al.  Islet Expression of M3 Uncovers a Key Role for Chemokines in the Development and Recruitment of Diabetogenic Cells in NOD Mice , 2008, Diabetes.

[44]  M. Gerstein,et al.  The Transcriptional Landscape of the Yeast Genome Defined by RNA Sequencing , 2008, Science.

[45]  L. Hood,et al.  Detailed transcriptome atlas of the pancreatic β cell , 2008 .

[46]  N. Barbosa-Morais,et al.  Tissue-specific splicing factor gene expression signatures , 2008, Nucleic acids research.

[47]  W. Zong,et al.  Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist , 2008, Oncogene.

[48]  B. Frey,et al.  Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing , 2008, Nature Genetics.

[49]  Pär Nordlund,et al.  Completing the family portrait of the anti‐apoptotic Bcl‐2 proteins: Crystal structure of human Bfl‐1 in complex with Bim , 2008, FEBS letters.

[50]  Marcel H. Schulz,et al.  A Global View of Gene Activity and Alternative Splicing by Deep Sequencing of the Human Transcriptome , 2008, Science.

[51]  S. Lenzen.  Oxidative stress: the vulnerable beta-cell. , 2008, Biochemical Society transactions.

[52]  J. Florez.  Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes? , 2008, Diabetologia.

[53]  L. Hood,et al.  Detailed transcriptome atlas of the pancreatic beta cell , 2009, BMC Medical Genomics.

[54]  D. Eizirik,et al.  Use of a systems biology approach to understand pancreatic beta-cell death in Type 1 diabetes. , 2008, Biochemical Society transactions.

[55]  B. Williams,et al.  Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.

[56]  Tatiana A. Tatusova,et al.  NCBI Reference Sequences: current status, policy and new initiatives , 2008, Nucleic Acids Res..

[57]  B. Hartmann,et al.  Decrypting the genome's alternative messages. , 2009, Current opinion in cell biology.

[58]  S. Pugazhenthi,et al.  Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-κB) signalling in human islets and in a mouse beta cell line , 2009, Diabetologia.

[59]  Torben F. Ørntoft,et al.  Cytokines Interleukin-1β and Tumor Necrosis Factor-α Regulate Different Transcriptional and Alternative Splicing Networks in Primary β-Cells , 2009, Diabetes.

[60]  P. Marchetti,et al.  Glucagon-Like Peptide-1 Agonists Protect Pancreatic β-Cells From Lipotoxic Endoplasmic Reticulum Stress Through Upregulation of BiP and JunB , 2009, Diabetes.

[61]  M. Gerstein,et al.  RNA-Seq: a revolutionary tool for transcriptomics , 2009, Nature Reviews Genetics.

[62]  H. Mewes,et al.  PPI spider: A tool for the interpretation of proteomics data in the context of protein–protein interaction networks , 2009, Proteomics.

[63]  F. Ortis,et al.  The role of inflammation in insulitis and β-cell loss in type 1 diabetes , 2009, Nature Reviews Endocrinology.

[64]  Lili Wan,et al.  RNA and Disease , 2009, Cell.

[65]  J. Manley,et al.  Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches , 2009, Nature Reviews Molecular Cell Biology.

[66]  D. Eizirik,et al.  Signaling by IL-1β+IFN-γ and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic β-cell apoptosis , 2009, Cell Death and Differentiation.

[67]  M. Bugliani,et al.  PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Interferon-γ–Induced Pancreatic β-Cell Apoptosis , 2009, Diabetes.

[68]  T. Ørntoft,et al.  STAT1 Is a Master Regulator of Pancreatic β-Cell Apoptosis and Islet Inflammation* , 2010, The Journal of Biological Chemistry.

[69]  P. Marchetti,et al.  p53 Up-regulated Modulator of Apoptosis (PUMA) Activation Contributes to Pancreatic β-Cell Apoptosis Induced by Proinflammatory Cytokines and Endoplasmic Reticulum Stress* , 2010, The Journal of Biological Chemistry.

[70]  Marcel H. Schulz,et al.  Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments , 2010, Nucleic acids research.

[71]  R. Guigó,et al.  Transcriptome genetics using second generation sequencing in a Caucasian population , 2010, Nature.

[72]  J. Fak,et al.  Chaolin Zhang and Its Combinatorial Controls Integrative Modeling Defines the Nova Splicing-Regulatory Network , 2013 .

[73]  I. Shimomura,et al.  Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes. , 2010, Endocrine journal.

[74]  T. Hughes,et al.  Most “Dark Matter” Transcripts Are Associated With Known Genes , 2010, PLoS biology.

[75]  J. Norris.  Infant and Childhood Diet and Type 1 Diabetes Risk: Recent Advances and Prospects , 2010, Current diabetes reports.

[76]  D. Eizirik,et al.  MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic β-cell responses to the viral by-product double-stranded RNA , 2009, Human molecular genetics.

[77]  F. Ortis,et al.  Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes , 2010, Diabetologia.

[78]  Catalin C. Barbacioru,et al.  RNA-Seq analysis to capture the transcriptome landscape of a single cell , 2010, Nature Protocols.

[79]  U. Boggi,et al.  Islet inflammation and CXCL10 in recent‐onset type 1 diabetes , 2010, Clinical and experimental immunology.

[80]  D. Clayton,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[81]  Mark I McCarthy,et al.  Genomics, type 2 diabetes, and obesity. , 2010, The New England journal of medicine.

[82]  M. V. von Herrath,et al.  Protection against or triggering of Type 1 diabetes? Different roles for viral infections , 2011, Expert review of clinical immunology.

[83]  Constantin Polychronakos,et al.  A Genome-Wide Meta-Analysis of Six Type 1 Diabetes Cohorts Identifies Multiple Associated Loci , 2011, PLoS genetics.

[84]  J. van Helden,et al.  Correction: Clusters of Conserved Beta Cell Marker Genes for Assessment of Beta Cell Phenotype , 2012, PLoS ONE.

[85]  P. Marchetti,et al.  Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death , 2011, Diabetes.

[86]  D. Eizirik,et al.  Exposure to the Viral By-Product dsRNA or Coxsackievirus B5 Triggers Pancreatic Beta Cell Apoptosis via a Bim / Mcl-1 Imbalance , 2011, PLoS pathogens.

[87]  P. Marchetti,et al.  PTPN2, a Candidate Gene for Type 1 Diabetes, Modulates Pancreatic β-Cell Apoptosis via Regulation of the BH3-Only Protein Bim , 2011, Diabetes.

[88]  上田 裕紀.  Etiology of type 1 diabetes , 2011 .

[89]  T. Ørntoft,et al.  Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation , 2012, Oncogene.